tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Inhibrx appoint Carlos Bais as Chief Scientific Officer
PremiumThe FlyInhibrx appoint Carlos Bais as Chief Scientific Officer
5M ago
Inhibrx reports Q4 EPS ($3.09) vs. ($6.93) last year
Premium
The Fly
Inhibrx reports Q4 EPS ($3.09) vs. ($6.93) last year
5M ago
Premium
Company Announcements
Inhibrx Biosciences Reports Promising Trial Results for INBRX-109
7M ago
PremiumCompany AnnouncementsInhibrx Biosciences Reveals Updated Corporate Presentation
1y ago
Inhibrx Inc (INBX) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Inhibrx Inc (INBX) Q2 Earnings Cheat Sheet
1y ago
Inhibrx initiated with a Market Perform at JMP Securities
Premium
The Fly
Inhibrx initiated with a Market Perform at JMP Securities
1y ago
Sanofi completes acquisition of Inhibrx
PremiumThe FlySanofi completes acquisition of Inhibrx
1y ago
Inhibrx stockholder approve sale to Sanofi
Premium
The Fly
Inhibrx stockholder approve sale to Sanofi
1y ago
INBX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INBX Upcoming Earnings Report: What to Expect?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100